AU5314894A - Novel derivatives of quinolonecarboxylic acid and naphthyridonecarboxylic acid - Google Patents

Novel derivatives of quinolonecarboxylic acid and naphthyridonecarboxylic acid

Info

Publication number
AU5314894A
AU5314894A AU53148/94A AU5314894A AU5314894A AU 5314894 A AU5314894 A AU 5314894A AU 53148/94 A AU53148/94 A AU 53148/94A AU 5314894 A AU5314894 A AU 5314894A AU 5314894 A AU5314894 A AU 5314894A
Authority
AU
Australia
Prior art keywords
acid
naphthyridonecarboxylic
quinolonecarboxylic
novel derivatives
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU53148/94A
Other versions
AU670470B2 (en
Inventor
Stephan Dr Bartel
Gerd Dr Kleefeld
Rainer Dr Neumann
Arnold Dr Paessens
Jurgen Dr Reefschlager
Thomas-J Dr Schulze
Gert Dr Streissle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU5314894A publication Critical patent/AU5314894A/en
Application granted granted Critical
Publication of AU670470B2 publication Critical patent/AU670470B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)

Abstract

The invention relates to novel quinolone- and naphthyridone-carboxylic acid derivatives of the general formula (I) <IMAGE> where the substituents have the meaning indicated in the description, processes for their preparation, and their use as medicaments, in particular as anti-viral agents.
AU53148/94A 1993-02-09 1994-01-12 Novel derivatives of quinolonecarboxylic acid and naphthyridonecarboxylic acid Ceased AU670470B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4303657A DE4303657A1 (en) 1993-02-09 1993-02-09 New quinolone and naphthyridonecarboxylic acid derivatives
DE4303657 1993-02-09

Publications (2)

Publication Number Publication Date
AU5314894A true AU5314894A (en) 1994-08-11
AU670470B2 AU670470B2 (en) 1996-07-18

Family

ID=6479930

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53148/94A Ceased AU670470B2 (en) 1993-02-09 1994-01-12 Novel derivatives of quinolonecarboxylic acid and naphthyridonecarboxylic acid

Country Status (15)

Country Link
EP (1) EP0612731B1 (en)
JP (1) JPH06271570A (en)
KR (1) KR940019702A (en)
AT (1) ATE157088T1 (en)
AU (1) AU670470B2 (en)
CA (1) CA2115021A1 (en)
DE (2) DE4303657A1 (en)
DK (1) DK0612731T3 (en)
ES (1) ES2105362T3 (en)
GR (1) GR3024686T3 (en)
HU (1) HUT70044A (en)
IL (1) IL108571A0 (en)
NZ (1) NZ250823A (en)
TW (1) TW248559B (en)
ZA (1) ZA94841B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU664237B2 (en) * 1992-02-27 1995-11-09 Janssen Pharmaceutica N.V. {(benzodioxan, benzofuran or benzopyran)-alkylamino} alkyl substituted guanidines as selective vascoconstrictors

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4425650A1 (en) * 1994-07-20 1996-01-25 Bayer Ag Substituted triazolylmethylphenylnaphthyridones
DE4425647A1 (en) * 1994-07-20 1996-01-25 Bayer Ag Heterocyclyl-1-phenyl substituted quinolonecarboxylic acids
DE4425659A1 (en) * 1994-07-20 1996-01-25 Bayer Ag New N1-diverse 6-fluoro-8-difluoromethoxy substituted quinolonecarboxylic acids
DE4425660A1 (en) * 1994-07-20 1996-01-25 Bayer Ag 7-Substituted 1- [4- (1H-1,2,4-triazol-1-yl-methyl) phenyl] substituted quinolone carboxylic acids
DE4425649A1 (en) * 1994-07-20 1996-01-25 Bayer Ag New 1- [4- (aminomethyl) phenyl] substituted quinolonecarboxylic acids
DE4425648A1 (en) * 1994-07-20 1996-01-25 Bayer Ag Novel 6 and 6,8-substituted 1- [4- (1H-1,2,4-triazol-1-ylmethyl) phenyl] quinolonecarboxylic acids
US5945431A (en) * 1996-03-15 1999-08-31 Biochem Therapeutics Incorporated Cytomegalovirus inhibiting compounds
GB9605437D0 (en) * 1996-03-15 1996-05-15 Iaf Biochem Int Cytomegalovirus inhibiting compounds
US6093737A (en) * 1996-12-30 2000-07-25 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5939439A (en) * 1996-12-30 1999-08-17 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6127390A (en) * 1997-10-02 2000-10-03 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
WO1999042106A1 (en) * 1998-02-19 1999-08-26 Sankyo Company, Limited Anti-hcmv agent
PE20011349A1 (en) 2000-06-16 2002-01-19 Upjohn Co 1-ARIL-4-OXO-1,4-DIHYDRO-3-QUINOLINE CARBOXAMIDES AS ANTIVIRAL AGENTS
KR20040041177A (en) 2001-09-26 2004-05-14 바이엘 파마슈티칼스 코포레이션 1,6-Naphthyridine Derivatives as Antidiabetics
DE60315796T2 (en) * 2002-01-17 2008-06-05 Merck & Co., Inc. HYDROXYNAPHTHYRIDINONCARBOXYL ACID AMIDES SUFFICIENT AS INHIBITORS OF THE HIV INTEGRASE
DE102004035203A1 (en) 2004-07-21 2006-02-16 Bayer Healthcare Ag Substituted quinolones
DE102005030524A1 (en) 2005-06-30 2007-01-18 Aicuris Gmbh & Co. Kg Substituted quinolones II
DE102006005861A1 (en) 2006-02-09 2007-08-23 Aicuris Gmbh & Co. Kg Substituted quinolones III

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ208470A (en) * 1983-07-18 1988-06-30 Abbott Lab 6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and antibacterial compositions containing such
AU5449590A (en) * 1989-04-28 1990-11-29 Daiichi Pharmaceutical Co., Ltd. Anti-hiv drug
DE3934082A1 (en) * 1989-10-12 1991-04-18 Bayer Ag CHINOLON CARBONIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS AN ANTIVIRAL AGENT
DE4123918A1 (en) * 1991-07-19 1993-01-21 Bayer Ag 8-VINYL AND 8-ETHINYL-CHINOLON CARBONIC ACIDS

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU664237B2 (en) * 1992-02-27 1995-11-09 Janssen Pharmaceutica N.V. {(benzodioxan, benzofuran or benzopyran)-alkylamino} alkyl substituted guanidines as selective vascoconstrictors

Also Published As

Publication number Publication date
HUT70044A (en) 1995-09-28
KR940019702A (en) 1994-09-14
TW248559B (en) 1995-06-01
ZA94841B (en) 1994-09-05
IL108571A0 (en) 1994-05-30
JPH06271570A (en) 1994-09-27
NZ250823A (en) 1995-04-27
CA2115021A1 (en) 1994-08-10
EP0612731A1 (en) 1994-08-31
AU670470B2 (en) 1996-07-18
DE4303657A1 (en) 1994-08-11
EP0612731B1 (en) 1997-08-20
GR3024686T3 (en) 1997-12-31
ES2105362T3 (en) 1997-10-16
HU9400352D0 (en) 1994-05-30
DE59403757D1 (en) 1997-09-25
DK0612731T3 (en) 1998-03-23
ATE157088T1 (en) 1997-09-15

Similar Documents

Publication Publication Date Title
AU5314894A (en) Novel derivatives of quinolonecarboxylic acid and naphthyridonecarboxylic acid
AU2724292A (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-d-neuraminic acid
CA2076589A1 (en) Naphthylethylureas and naphthylethylthioureas, the process for their preparation and pharmaceutical compositions holding same
AU6194994A (en) Monomeric bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
AU6194694A (en) Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
AU657608B2 (en) Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as pharmaceuticals
AU6194794A (en) Tetrazole derivatives of bile acids, processes for their preparation and the use of these compounds as medicaments
AU673893B2 (en) New pyridothiadiazones, processes for their preparation and the pharmaceutical compositions which contain them
GR3019796T3 (en) Quinolone carboxylic acid derivatives, process for their preparation and their use
IL105646A0 (en) Sulfonylbenzyl-substituted benzo-and pyridopyridones,their preparation and pharmaceutical compositions containing them
IL112020A0 (en) Arylacetic acid derivatives, their preparation and their use as fungicides
AU1413788A (en) Dihydropyridinamides process for their preparation, and their use in medicaments
EP0331092A3 (en) Alpha-amino-carboxylic-acid derivatives, their preparation and use
AU1264488A (en) Substituted pyridine-2,4-dicarboxylic acid derivatives, processes for their preparation, the use thereof and medicaments based on these compounds
AU656674B2 (en) New thiochroman compounds, processes for the preparation thereof, and pharmaceutical compositions containing them
AU6187394A (en) New pyrrolopyrazine compounds, processes for their preparation and the pharmaceutical compositions which contain them
CA2119661A1 (en) New n-benzylpiperazine compounds, their preparation process and pharmaceutical compositions containing them
AU668398B2 (en) New aminoalkylchromones, processes for the preparation thereof, and pharmaceutical compositions containing them
AU3188893A (en) Alpha-aryl-alpha-hydroxy-beta-imidazolinyl-propionamides
AU1866192A (en) New process for the synthesis of enantiomers of 3-aminochroman compounds
AU659738B2 (en) New pyrrolothienopyrazine compounds, processes for the preparation thereof, and pharmaceutical compositions containing them